Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome

Emre Uysal,Omer Tammo,Esra Soylemez,Mehmet Incebıyık,Dilber Filiz,Mesut Alci
DOI: https://doi.org/10.1186/s12902-024-01701-6
2024-08-31
BMC Endocrine Disorders
Abstract:Polycystic ovary syndrome (PCOS) is a prevalent hormonal disorder affecting 5–15% of women of reproductive age, characterized by ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology. PCOS is associated with metabolic disturbances such as dyslipidemia, insulin resistance (IR), and an increased risk of type 2 diabetes (T2DM) and cardiovascular disease.
endocrinology & metabolism
What problem does this paper attempt to address?